TRACON PHARMACEUTICALS INC's ticker is TCON and the CUSIP is 89237H209. A total of 27 filers reported holding TRACON PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $67,000 | -19.3% | 40,179 | -2.7% | 0.00% | – |
| Q2 2022 | $83,000 | -61.8% | 41,279 | -50.0% | 0.00% | -100.0% |
| Q1 2022 | $217,000 | -60.9% | 82,500 | -58.8% | 0.00% | 0.0% |
| Q4 2021 | $555,000 | -55.2% | 200,404 | -37.3% | 0.00% | -66.7% |
| Q3 2021 | $1,238,000 | -23.7% | 319,775 | +27.9% | 0.00% | -25.0% |
| Q2 2021 | $1,623,000 | -36.3% | 250,059 | -19.2% | 0.00% | -42.9% |
| Q1 2021 | $2,547,000 | -10.9% | 309,487 | +26.7% | 0.01% | -12.5% |
| Q4 2020 | $2,859,000 | +1543.1% | 244,362 | +175.4% | 0.01% | +700.0% |
| Q2 2020 | $174,000 | +185.2% | 88,728 | +148.6% | 0.00% | – |
| Q1 2020 | $61,000 | – | 35,686 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 4,764,508 | $848,082 | 0.28% |
| Ikarian Capital, LLC | 2,765,530 | $492,265 | 0.06% |
| JOHNSON & JOHNSON | 84,003 | $14,953 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 258,844 | $46,074 | 0.00% |
| BlackRock Inc. | 267,821 | $47,673 | 0.00% |
| Bank of New York Mellon Corp | 10,259 | $1,826 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 15,835 | $2,819 | 0.00% |
| Truvestments Capital LLC | 318 | $57 | 0.00% |
| Tower Research Capital LLC (TRC) | 10,407 | $1,852 | 0.00% |
| Cutler Group LLC / CA | 1,200 | $0 | 0.00% |